Rare Disease Drug Development

图书简介

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and the optimization of rare disease registries. The book addresses various rare disease drug development processes by disciplines such as oncology, hematology, pediatrics, and gene therapy. Chapters then address the operational aspects of drug development, including approval processes, development accelerations, and market access strategies. The book concludes with reflections on the authors’ case for real-world data and evidence generation in orphan medicinal drug development. Rare Disease Drug Development is an expertly written text optimized for biopharmaceutical R

Introduction to Rare Diseases and Market Overview.- The Patient Perspective.- Select Patient Narratives.- The Caregiver Perspective.- The Critical, Multidimensional Role of Patient Advocacy Groups in Rare Disease.- A Mental Health Perspective.- Investment Decisions Related to Rare Disease Drug Development.- Optimizing Rare Disease Registries and Natural History Studies.- Novel Approaches to Clinical Trials in Rare Diseases.- Patient Benefits from Innovative Designs in Rare Diseases.- Central Nervous System Rare Disease Drug Development.- Oncologic Rare Disease Drug Development .- Hematologic Rare Disease Drug Development.- Lessons From Rare Disease and Gene Therapy Clinical Studies in Ophthalmology.- Rare Diseases in the Pediatric Population.- Cell and Gene Therapy in Rare Diseases.- The Feasibility Assessment.- The Evolving Regulatory Space and the Advent of Patient-Focused Drug Development.- Operational Aspects of Rare Disease Drug Development.- Accelerating Rare Disease Drug Development.- Select Rare Disease Drug Approvals: Lessons Learned.- A Rapid Market Access Strategy for Orphan Medicinal Products (OMPs) with Highlights Regarding the Pricing and Reimbursement Process and Barriers to Patient Use.- Integrated Life Cycle Management for Rare and Orphan Products.- The Case for Real-World Data and Real-World Evidence Generation in Rare and Orphan Medicinal Drug Development.- Closing Remarks.-

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Rare Disease Drug Development 罕见病药物开发：临床、科学、患者与护理者展望 药物化学

Rare Disease Drug Development

罕见病药物开发：临床、科学、患者与护理者展望
药物化学